Back to today’s briefing

Story perspectives

FDA Clears MRI Software for Neurodegenerative and Vulvar Diagnosis

1/14/2025

46 4

Summary

Story summary

Oxford Brain Diagnostics' CDM Insights software has gained FDA 510(k) clearance, revolutionizing the assessment of brain microstructures through MRI, which is vital for diagnosing neurodegenerative disorders. Simultaneously, MRI plays a key role in identifying rare vulvar pathologies, highlighting the need for a deep understanding of vulvar anatomy to ensure precise diagnoses and effective surgical strategies.

1 of 1

Story summary

Oxford Brain Diagnostics' CDM Insights software has gained FDA 510(k) clearance, revolutionizing the assessment of brain microstructures through MRI, which is vital for diagnosing neurodegenerative disorders. Simultaneously, MRI plays a key role in identifying rare vulvar pathologies, highlighting the need for a deep understanding of vulvar anatomy to ensure precise diagnoses and effective surgical strategies.